Windtree to Present at the Dawson James Small Cap Growth Conference on October 12th
WARRINGTON, Pa. , Oct. 03, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, today announced that Craig Fraser , President and Chief Executive
Article Date
October 3, 2023
This article is featured on another website.
Go to article
September 11, 2026
Data Governance and Geopolitics: The New Operational Reality of Global Clinical Trials
Part 4 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
September 11, 2026
Data Governance and Geopolitics: The New Operational Reality of Global Clinical Trials
Part 4 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
July 10, 2026
Sarcoma Clinical Trials – Cell Therapy’s Solid-Tumor Breakthrough, and What It Means for a Rare Cancer
A Turning Point for Cell Therapy in Solid Tumors, and for Sarcoma For most of…
July 10, 2026
Sarcoma Clinical Trials – Cell Therapy’s Solid-Tumor Breakthrough, and What It Means for a Rare Cancer
A Turning Point for Cell Therapy in Solid Tumors, and for Sarcoma For most of…